CIK 0001768446 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Climb Bio, Inc.
Sign in to watch- Ticker
- CLYM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832273741
- Phone
- 1-866-857-2596
- Business address
- 20 WILLIAM STREET, SUITE G50, WELLESLEY HILLS, MA
- Former names
- Eliem Therapeutics, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement · Results of operations · Other events
- 4 Option exercise Director acquired 50,188 shares (option exercise)
- 4 Planned sale CHIEF ACCOUNTING OFFICER sold 1,235 shares at $2.02 ($2,495)
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- SC 13G/A Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- S-3 Offering Registration Statement
- 8-K Event Results of operations · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Bylaws or fiscal year change · Other events
- 4 Planned sale CHIEF ACCOUNTING OFFICER sold 1,191 shares at an average $8.18 ($9,741)
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
Page 7 of 17 · 326 filings